menu
    • menu

    Company profile for Celldex Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Celldex TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    53 Frontage Road, Suite 220 Hampton, NJ 08827
    Telephone
    Telephone
    (908) 454-7120
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://celldex.com/
    Linkedin
    Linkedin
    http://www.linkedin.com/company/597166
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/search?q=celldex

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LB Pharma, Celldex Hire Commercial Heads As Launch Plans Ramp Up
    LB Pharma, Celldex Hire Commercial Heads As Launch Plans Ramp Up

    14 Nov 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/lb-and-celldex-hire-commercial-chiefs-launch-plans-ramp

    FIERCE PHARMA
    14 Nov 2025
    Share Share
    Celldex Names Teri Lawver as Chief Commercial Officer
    Celldex Names Teri Lawver as Chief Commercial Officer

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184537/24180/en/Celldex-Announces-Appointment-of-Teri-Lawver-as-Chief-Commercial-Officer.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Celldex Unveils Q3 2025 Financials & Corporate Progress
    Celldex Unveils Q3 2025 Financials & Corporate Progress

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185035/24180/en/Celldex-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Celldex To Present At Upcoming Investor Conferences
    Celldex To Present At Upcoming Investor Conferences

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183615/24180/en/Celldex-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Celldex Reveals Positive Phase 2 Results For Barzolvolimab
    Celldex Reveals Positive Phase 2 Results For Barzolvolimab

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182511/24180/en/Celldex-Presents-Results-from-Barzolvolimab-Phase-2-Study-in-Cold-Urticaria-ColdU-and-Symptomatic-Dermographism-SD-Demonstrating-Sustained-Efficacy-and-Favorable-Safety-Profile-ove.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Celldex Reports Positive Phase 1 Results For CDX-622 Showing
    Celldex Reports Positive Phase 1 Results For CDX-622 Showing

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177884/24180/en/Celldex-Announces-Initial-Positive-Results-from-Phase-1-Trial-of-CDX-622-Demonstrating-Favorable-Safety-and-PK-Profile-and-Sustained-Mast-Cell-Inhibition.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search